Wilson Sonsini Goodrich & Rosati advised Dren Bio on the transaction. Dren Bio, Inc., a privately held, clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune,...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sana Biotechnology on the offering, and Cooley advised the underwriters. Sana Biotechnology, Inc. (Nasdaq: SANA) announced the closing of its...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Alaska Airlines on the deal, and Wilson Sonsini Goodrich & Rosati advised Hawaiian Airlines. Alaska Airlines, which serves more than 120 destinations across the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Assembly Bio on the transaction, and Ropes & Gray advised Gilead Sciences, Inc. Assembly Biosciences (Nasdaq: ASMB) and Gilead Sciences (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IGM Biosciences, Inc. on the transaction. IGM Biosciences, Inc. (IGM) announced the closing of its previously announced upsized underwritten public offering...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Pyxis Oncology, Inc. on the transaction, while Wilson Sonsini advised Apexigen on the transaction. Pyxis Oncology, Inc., a clinical-stage company, and Apexigen,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Winstead PC advised Hawaiian Airlines on the deal. Hawaiian Holdings, Inc., the parent company of Hawaiian Airlines, Inc., announced an agreement with Amazon.com,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Enliven Therapeutics on the deal. Enliven Therapeutics, a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase...
You must be a Standard 1 Year member to access this content.
